<strong>Creativity</strong> and <strong>Innovation</strong><br /> for the patient Development of <strong>new therapies</strong> and <br /><strong>treatments</strong> to improve citizens health <strong>Internationally renowned</strong><br /> biomedical research

Creativity and Innovation
for the patient

Development of new therapies and
treatments to improve citizens health

Internationally renowned
biomedical research

Home

José A. Oteo Revuelta

José A. Oteo Revuelta

José Antonio Oteo

Email: jaoteo@riojasalud.es

Phone: +34 941 278 770 (Ext.: 89871)

Biosketch

José Antonio Oteo (MD, PhD in Medicine and Surgery, University of Navarra, 1990) is a Specialist in Internal Medicine (MIR Program carried out at Hospital Virgen del Camino, Pamplona, Spain). He has been the Head of the Internal Medicine Service of the Hospital of La Rioja and Hospital San Millán-San Pedro- in La Rioja. He is currently the Head of the Infectious Diseases Department (formerly known as Clinical Management Area) at the Hospital San Pedro, La Rioja (Spain). He is also the Head of the Infectious Diseases Department of the Center for Biomedical Research of La Rioja (CIBIR), which includes three units: the Laboratory of Special Pathogens (Center of Rickettsiosis and Arthropod-Borne Diseases); the Unit of Infectious Diseases, Microbiota and Metabolism and the Unit of Infections, Inflammation and Aging. In this research center, he manages and supervises a laboratory equipped with the latest technologies in molecular and cellular biology and a biosafety level-3 facility for handling dangerous and fastidious microorganisms.

In the field of arthropod vectors research, the group that he leads has been pioneer in the description of new tick-borne diseases, such as DEBONEL, and/or non-previously described illnesses in our environment. They have also significantly contributed to the isolation and involvement of new microorganisms in human pathology, such as Rickettsia monacensis or the new Rickettsia rioja. Besides, other Rickettsia spp., such as Rickettsia vini or Rickettsia colombianensi (to date no associated with human diseases), have been characterized. The biggest series of patients with Lyme disease in Spain and studies in the arthropod vectors have been also reported by this group. The first cases of human anaplasmosis in the South of Europe, the first cases of Rickettsia sibirica mongolitimonae infection, the first implication of Rickettsia massiliae as human pathogen in America, the first case of neurotoxic paralysis after tick-bite, the circulation of Ca. Neoehrlichia mikurensis in Spain, and the description of tularemia after tick-bite are among other relevant achievements. The first cluster of cases of human Rickettsia felis infection in Spain and the first infestation with trombiculid mites (Neotrombicula inopinata) as causative agents of seasonal dermatitis in the world have been also described by this group. It is also worth mentioning the first description of Crimean-Congo hemorrhagic fever in ticks from Occidental Europe and in ticks removed from migratory birds in the North of Africa. These findings were essential for a rapid health response to the first two autochthonous cases detected in Spain in August-September 2016. In addition, this group has managed more than 1 million euros in research funding in recent years.

Concerning his activity in the Unit of Infectious Diseases, Microbiota and Metabolism he has focused his interest on the study of gut microbiota composition in different infectious and relevant pathologies through next-generation technologies. He has also been involved in the analyses of data obtained by transcriptomics and lipidomics in order to find out early biomarkers of these pathologies. In addition, he has also participated in several national and international projects in this field and has published several studies in high impact journals.

His experience in lecturing includes the post-graduate training of resident doctors, his involvement in several PhD courses carried out in different Universities as well as his contributions as Invited Professor in several courses in the field of Medicine and Nursing. He is the Professor in charge of the practices of medical students in the Hospital San Pedro and the person in charge of lecturing Physiology-I in the Degree of Nursing of the University of La Rioja. He has supervised several Doctoral Theses, Diploma of Advanced Studies (DEAs), Master Projects and Final-Degree Projects. He is accredited by the ANECA as Profesor Titular de Universidad in the area of Medicine.

As result of his research activity, he has published more than 350 publications in scientific journals, books and monographs. During his professional practice he has participated, as principal investigator (PI) in most cases, in numerous competitive research projects.

He currently leads a clinical group associated with the Spanish Infectious Pathology Research Network (REIPI); his team is also part of the Spanish AIDS Research Network (RIS); he is an expert of the VectorNet network, which depends on the ECDCs, and is member of the European Network for Neglected Vectors and Vector-Borne Infections (EurNegVec Cost Action). Recently, his team has joined the Network of Biological Alert Laboratories (RE-LAB), set up to respond to threats by dangerous biological agents. His contributions frequently appear in official programs of national and international congresses of relevance in the field of infectious diseases. He has been the Chairman of the Scientific Committee of the Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and President of several National and International Study Groups, such as the Special Pathogens group of the SEIMC and the Coxiella, Anaplasma, Rickettsia and Bartonella group from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). He is part of the editorial committee of several scientific journals and acts as evaluator of the National Agency for Evaluation and Prospecting (ANEP) and of different agencies from other countries such as Portugal, Norway and Argentina. He has also the honor of having received numerous scientific and social awards.

Publications

 

ncbi

Date

11 April 2017

Categories

Arthropod Vectors, Infectious Diseases, Microbiota and Metalobism, Inflammation and Ageing Unit

Partners

La Rioja Crece con Europa. Programa Operativo FEDER de La Rioja, 2014-2020

Unesco, Organización de las naciones unidas para la educación la ciencia y la cultura. Centro Nacional de Documentación y Bioética

Diploma de compromiso con la excelencia

Etiqueta de calificación energética

ISO 14001:2015

© 2021 Rioja Salud - C/ Piqueras, 98 – 3ª Planta · 26006 · Logroño · La Rioja · Telf.: 941 278 855 · Fax: 941 278 887